Literature DB >> 18356759

Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder.

Eric A Storch1, Lisa J Merlo2, Michael J Larson2, Gary R Geffken2, Heather D Lehmkuhl2, Marni L Jacob2, Tanya K Murphy2, Wayne K Goodman2.   

Abstract

OBJECTIVE: To examine the impact of psychiatric comorbidity on cognitive-behavioral therapy response in children and adolescents with obsessive-compulsive disorder.
METHOD: Ninety-six youths with obsessive-compulsive disorder (range 7-19 years) received 14 sessions of weekly or intensive family-based cognitive-behavioral therapy. Assessments were conducted before and after treatment. Primary outcomes included scores on the Children's Yale-Brown Obsessive-Compulsive Scale, response rates, and remission status.
RESULTS: Seventy-four percent of participants met criteria for at least one comorbid diagnosis. In general, participants with one or more comorbid diagnoses had lower treatment response and remission rates relative to those without a comorbid diagnosis. The number of comorbid conditions was negatively related to outcome. The presence of attention-deficit/hyperactivity disorder and disruptive behavior disorders was related to lower treatment response rates, and the presence of disruptive behavior disorders and major depressive disorder were related to lower remission rates.
CONCLUSIONS: The presence of a comorbid disorder, particularly disruptive behavior, major depressive, and attention-deficit/hyperactivity disorders, has a negative impact on treatment response. Assessing for psychiatric disorders before treatment entry and treating these comorbid conditions before or during cognitive-behavioral therapy may improve final outcome. Comorbid anxiety or tic disorders do not seem to negatively affect response.

Entities:  

Mesh:

Year:  2008        PMID: 18356759     DOI: 10.1097/CHI.0b013e31816774b1

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  56 in total

1.  The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders.

Authors:  Eric A Storch; Elysse B Arnold; Anna M Jones; Chelsea M Ale; Jeffrey J Wood; Jill Ehrenreich-May; Adam B Lewin; P Jane Mutch; Tanya K Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

2.  Frequency and correlates of suicidal ideation in pediatric obsessive-compulsive disorder.

Authors:  Eric A Storch; Regina Bussing; Marni L Jacob; Joshua M Nadeau; Erika Crawford; P Jane Mutch; Dana Mason; Adam B Lewin; Tanya K Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2015-02

3.  Inter-rater Reliability of the Anxiety Disorders Interview Schedule for DSM-IV in High-Functioning Youth with Autism Spectrum Disorder.

Authors:  Danielle Ung; Elysse B Arnold; Alessandro S De Nadai; Adam B Lewin; Vicky Phares; Tanya K Murphy; Eric A Storch
Journal:  J Dev Phys Disabil       Date:  2014-02-01

4.  Intensive Family-Based Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder: Applications for Treatment of Medication Partial- or Nonresponders.

Authors:  Wendi E Marien; Eric A Storch; Gary R Geffken; Tanya K Murphy
Journal:  Cogn Behav Pract       Date:  2009-08

Review 5.  Psychotherapy for obsessive-compulsive disorder.

Authors:  Eric A Storch; Amy Mariaskin; Tanya K Murphy
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

6.  Obsessive-compulsive disorder: Evidence-based treatments and future directions for research.

Authors:  Caleb W Lack
Journal:  World J Psychiatry       Date:  2012-12-22

7.  Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.

Authors:  Christine A Conelea; Michael R Walther; Jennifer B Freeman; Abbe M Garcia; Jeffrey Sapyta; Muniya Khanna; Martin Franklin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-10-02       Impact factor: 8.829

8.  A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.

Authors:  Joseph F McGuire; John Piacentini; Adam B Lewin; Erin A Brennan; Tanya K Murphy; Eric A Storch
Journal:  Depress Anxiety       Date:  2015-06-30       Impact factor: 6.505

9.  D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.

Authors:  Sabine Wilhelm; Noah Berman; Brent J Small; Rachel Porth; Eric A Storch; Daniel Geller
Journal:  J Affect Disord       Date:  2018-07-20       Impact factor: 4.839

10.  Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder.

Authors:  Audra K Langley; Adam B Lewin; R Lindsey Bergman; Joyce C Lee; John Piacentini
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-03-28       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.